Showing 181 - 200 results of 224,831 for search '(( a non decrease ) OR ( 10 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.48s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191

    Overexpression of human PGRN mRNA prevents the decrease in axon outgrowth produced by knockdown of zebrafish PGRN. by Angela S. Laird (360986)

    Published 2013
    “…<p>A) The decreased axonal length produced by knockdown of <i>grna</i> with a 5′UTR MO was rescued by co-expression of PGRN mRNA. * significantly different from grna CO MO, p<0.02; ̂ significantly different from <i>grna</i> MO + GFP, p<0.0001. …”
  12. 192
  13. 193
  14. 194
  15. 195

    <i>USP28</i> protein level was decreased by hypoxia signaling via both protein degradation and transcriptional repression in A549 cells. by Qin Li (36669)

    Published 2013
    “…<p>(A) A549 cells were transfected with non-coding control siRNA or siRNA targeting human <i>HIF-1α</i> and <i>HIF-2α</i> (<i>HIF-1α</i> RNAi and <i>HIF-2α</i> RNAi mixture) for 48 hr, and then were treated with 1.0 mM NiSO<sub>4</sub> or cultured in 1% O<sub>2</sub> (Hy) for another 24 hr. …”
  16. 196
  17. 197
  18. 198
  19. 199

    Non-Pneumatic Anti-Shock Garment (NASG), a First-Aid Device to Decrease Maternal Mortality from Obstetric Hemorrhage: A Cluster Randomized Trial by Suellen Miller (294598)

    Published 2013
    “…<div><p>Background</p><p>Obstetric hemorrhage is the leading cause of maternal mortality. Using a cluster randomized design, we investigated whether application of the Non-pneumatic Anti-Shock Garment (NASG) before transport to referral hospitals (RHs) from primary health care centers (PHCs) decreased adverse outcomes among women with hypovolemic shock. …”
  20. 200

    Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

    Published 2021
    “…Promoter activity was decreased after inhibition of PKC. (B) Combined treatment with 10 nM Gö-6983 + 10 nM PMA in comparison to a control with 10 nM PMA also led to a reduction in <i>GRK6</i> promoter activity. …”